IInflammatix Team
Inflammatix
Last updated: February 23, 2026
Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical
Khosla Ventures, $102M Series D in 2021
Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical
Khosla Ventures, $102M Series D in 2021
- Series D • Khosla Ventures, $102M Series D in 2021
Founder Intelligence Brief: Inflammatix Team
This profile is built to help readers move from a founder name to decision-ready context. Inflammatix Team is mapped to Inflammatix in the Healthcare category, with current stage context as Series D. The primary operating market is San Francisco Bay Area, California, USA, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $102.00M, with the latest mapped round as Series D (Khosla Ventures, $102M Series D in 2021). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Healthcare startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Healthcare industry routes and Series D stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: United States directory.
- Stage signal: Series D funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Healthcare.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About Inflammatix Team
Common questions people ask about this profile.
Who is Inflammatix Team?
Inflammatix Team is the founder profile listed on 100Xfounder for Inflammatix, tracked for market signals, company intelligence, and operator-level context.
What does Inflammatix do?
Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical
Where is Inflammatix based?
Inflammatix is listed as operating from San Francisco Bay Area, California, USA.
What is the current funding stage of Inflammatix?
Inflammatix is currently categorized at Series D on 100Xfounder. Funding signal: Khosla Ventures, $102M Series D in 2021
What is the latest funding round for Inflammatix?
The latest tracked round for Inflammatix is Series D Khosla Ventures, $102M Series D in 2021. Total tracked rounds: 1.
Is Inflammatix hiring right now?
Current hiring signal for Inflammatix: Open Roles.
Is Inflammatix Team's profile verified?
Yes. Inflammatix Team's profile is marked as verified on 100Xfounder as of March 3, 2026.
How can I connect with Inflammatix Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for inflammatix.com.
What technologies are associated with Inflammatix?
Inflammatix is associated with Python, GCP, BigQuery, and React based on current profile intelligence.